Journey Medical Corp Announces New Journey with the Experts Video Featuring Kathleen Colorado, MD
Dr. Colorado discusses furunculosis, a skin condition affecting more than 200,000 people yearly in the United States
Furunculosis is a skin infection that forms painful, pus-filled lumps called furuncles. A furuncle (abscess) forms when a hair follicle becomes infected and inflamed. To view the Journey with the Experts video featuring Dr. Colorado, please visit https://vimeo.com/
About Journey with the Experts
Journey with the Experts is an educational initiative supported by Journey Medical Corporation, the medical dermatology company. The initiative is designed to educate the general public on common medical dermatology skin disorders and explain how these conditions can be treated at local dermatology practices.
The information, including, without limitation, topics, presentations, discussions, content, descriptions or any other material contained herein is for informational purposes only. None of the material herein is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified HCP with any questions you may have regarding a medical condition or treatment and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay seeking it because of something you have heard, observed, or inferred herein. Any reliance is strictly prohibited.
About Journey Medical Corporation
Journey Medical is focused on identifying, acquiring and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. The company currently markets five products that help treat and heal common skin conditions. The Journey Medical team is comprised of industry experts with extensive experience commercializing some of the most successful prescription dermatology brands. Journey Medical is located in Scottsdale, Arizona and is a partner company of Fortress Biotech, Inc. (NASDAQ:FBIO)
About Kathleen Colorado, MD
Dr. Colorado is a board-certified dermatologist who has lived and worked in Tampa for over 20 years. She is the Medical Director of Colorado Health and Youth Dermatology Centers. Additionally, Dr. Colorado serves as an Assistant Clinical Professor of Dermatology at the University of South Florida (USF) College of Medicine, where she teaches and mentors the dermatologists of the future, medical students and resident physicians.
Dr. Colorado received her Doctor of Medicine (MD) degree from the USF College of Medicine. She graduated second in her medical school class with a 4.0 GPA and Highest Honors. She earned membership into the exclusive and prestigious Alpha Omega Alpha (AOA) Medical Honor Society. She then completed her specialty residency training in Dermatology and Cutaneous Surgery at the USF College of Medicine Department of Dermatology. Dr. Colorado has also completed post-graduate certification in laser therapies, Tumescent Laser Liposuction and Mohs micrographic surgery. For additional information about Dr. Colorado, please visit https://www.dermatologykathleencoloradomd.com/
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. As used below and throughout this press release, the words "we", "us" and "our" may refer to Fortress individually, a partner company individually, or Fortress together with one or more partner companies, as dictated by context. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships;
Jaclyn Jaffe and William Begien
Fortress Biotech, Inc.
Page Updated Last on: Sep 20, 2021